Intelligent Trials Success Stories – Computer Business Review

Clinical trials are getting increasingly complex, challenging their very planning and execution. To meet these challenges, AI-enabled technologies and advanced analytics become a true necessity. Intelligent Trials’ out-of-the-box solutions improve operational outcomes by providing cross-industry performance metrics, predictive models, and forecasting capabilities. The full suite of offerings for Intelligent Trials includes Study Design, Study Feasibility, […]

Vanguard readies for life after LIBOR

Bloomberg has estimated the exposure of all financial instruments using LIBOR as a benchmark reference rate at $200 trillion in the United States and $350 trillion globally.1 Why LIBOR is going away Owing to a decline in short-term interbank lending volume, LIBOR has...